Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
21
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 21 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Xolair Omalizumab · J2357 | B | $415M | -1% | 17,605 | $23,566 | $37.24 |
| Advair HFA Fluticasone Propion/Salmeterol | D | $321M | -20% | 200,081 | $1,602 | $28.71 |
| Xolair Omalizumab | D | $313M | +23% | 11,011 | $28,437 | $1,381.49 |
| Winrevair Sotatercept-Csrk | D | $178M | n/a | 1,923 | $92,367 | $16,651.03 |
| Letairis Ambrisentan | D | $82.7M | -7% | 1,309 | $63,163 | $408.89 |
| Advair Diskus Fluticasone Propion/Salmeterol | D | $71.2M | -92% | 109,574 | $650 | $3.26 |
| Zemaira Alpha-1-Proteinase Inhibitor | D | $33.1M | +19% | 282 | $117,338 | $0.57 |
| Airsupra Albuterol Sulfate/Budesonide | D | $24.8M | +2584% | 25,835 | $961 | $43.56 |
| Cinqair Reslizumab · J2786 | B | $8.6M | -12% | 302 | $28,477 | $9.91 |
| Winrevair (2 Pack) Sotatercept-Csrk | D | $7.1M | n/a | 46 | $153,535 | $28,250.39 |
| Singulair Montelukast Sodium | D | $5.7M | -14% | 2,574 | $2,222 | $8.34 |
| Tudorza Pressair Aclidinium Bromide | D | $5.1M | -52% | 1,936 | $2,614 | $383.18 |
| Proair Respiclick Albuterol Sulfate | D | $4.5M | -62% | 34,657 | $131 | $65.66 |
| Cinqair Reslizumab | D | $962K | +1% | 26 | $37,010 | $106.44 |
| Proair Digihaler Albuterol Sulfate | D | $406K | -51% | 3,126 | $130 | $90.48 |
| Armonair Digihaler Fluticasone Propionate | D | $336K | -6% | 521 | $645 | $276.95 |
| Airduo Digihaler Fluticasone Propion/Salmeterol | D | $277K | -57% | 353 | $784 | $422.11 |
| Airduo Respiclick Fluticasone Propion/Salmeterol | D | $257K | +24% | 346 | $743 | $362.27 |
| Oralair Gr Pol-Orc/Sw Ver/Rye/Kent/Tim | D | $70K | -20% | 27 | $2,607 | $14.66 |
| Duaklir Pressair Aclidinium Brom/Formoterol Fum | D | $60K | +21% | 64 | $930 | $347.33 |
| Proair HFA Albuterol Sulfate | D | $42K | -96% | 428 | $98 | $8.18 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.